glp-1 nad The NAD+ Mistake Many People Make on Science's 2023 Breakthrough: GLP-1R Agonists

Avoid Research Chemicals : Unapproved peptides can lead to unpredictable results and unwanted side effects

Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents (Toxicology and Applied Pharmacology)

Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents (49)

However, the authors concluded that more studies are needed to better understand whether supplementing with calcium alone is effective for GLP-1 secretion, or if the effects only occur when its combined with other nutrients